Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters
- 29 June 2001
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 194 (3) , 318-326
- https://doi.org/10.1002/1096-9896(200107)194:3<318::aid-path881>3.0.co;2-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancerGenes, Chromosomes and Cancer, 1999
- Angewandte StatistikPublished by Springer Nature ,1999
- Genetic alterations in breast cancerGenes, Chromosomes and Cancer, 1995
- Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancerBritish Journal of Cancer, 1995
- Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patientsBritish Journal of Cancer, 1994
- Two species of human CRK cDNA encode proteins with distinct biological activities.Molecular and Cellular Biology, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer.Proceedings of the National Academy of Sciences, 1991
- p53 gene mRNA expression and chromosome 17p allele loss in breast cancerBritish Journal of Cancer, 1990
- At Last—Worldwide Agreement on the Staging of CancerArchives of Surgery, 1987